Engineered Stem Cells Provide Cancer-Killing iNKT Cells.

Engineered Stem Cells Provide Cancer-Killing iNKT Cells.
Cell Stem Cell. 2019 Oct 03;25(4):454-455
Authors: Murray MP, Kronenberg M
Abstract
Invariant natural killer T (iNKT) cells have been tested for their potential use in cancer immune therapy, but their low frequency has limited their use. In this issue, Zhu and colleagues propose to overcome this by engineering hematopoietic stem cells (HSCs) to provide a continual source of iNKT cells. (Zhu et al., 2019).
PMID: 31585091 [PubMed - in process]

Source: Cell Stem Cell - October 2, 2019 Category: Stem Cells Authors: Murray MP, Kronenberg M Tags: Cell Stem Cell Source Type: research